CASP3 and lung cancer: The HTB182 and CRL5985 lung cancer cells were treated either with cisplatin (10 μM) alone or in combination with both caffeine (2 mM) and cisplatin (10 μM) for 36 hours and caspase-3 activity was determined (Figure 1).